Postgraduate Medical Journal 1990-01-01

Clinical pharmacokinetic studies with lornoxicam.

P Turner, A Johnston

Index: Postgrad. Med. J. 66 Suppl 4 , S28-9, (1990)

Full Text: HTML

Abstract

Pharmacokinetic data from several studies in young and elderly human subjects are reviewed. Lornoxicam appears to be extensively metabolized and no unchanged drug has been found in the urine. It has a relatively short elimination half-life (about 4 hours), and no significant differences in pharmacokinetic data have been found between young and elderly volunteers.

Related Compounds

  • Lornoxicam

Related Articles:

Intra-articular levobupivacaine, lornoxicam and morphine analgesia after knee arthroscopy: a randomized, controlled trial.

2012-01-01

[Acta Orthop. Traumatol. Turc. 46(6) , 411-5, (2012)]

Characterization of two polymorphs of lornoxicam.

2013-01-01

[J. Pharm. Pharmacol. 65(1) , 44-52, (2013)]

Investigation on the micelle-sensitized Ce(IV)-lornoxicam-Rh B chemiluminescence system and its application.

2012-01-01

[J. Fluoresc. 22(1) , 529-35, (2012)]

Enhanced targeting efficiency of PLGA microspheres loaded with Lornoxicam for intra-articular administration.

2011-01-01

[Drug Deliv. 18(7) , 536-44, (2011)]

Overview of the pharmacological properties, pharmacokinetics and animal safety assessment of lornoxicam.

1990-01-01

[Postgrad. Med. J. 66 Suppl 4 , S18-21, (1990)]

More Articles...